AC Immune SA (ACIU)
USD 1.72
(2.99%)
USD 1.72
(2.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 14.8 Million | 3.93 Million | - | 15.43 Million | 111.02 Million | 7.19 Million |
| Cost of Revenue | 54.6 Million | 60.33 Million | 62.28 Million | 59.48 Million | 50.43 Million | 44.27 Million |
| Gross Profit | -39.8 Million | -56.4 Million | -62.28 Million | -44.05 Million | 60.59 Million | -37.08 Million |
| Operating Expenses | 13.81 Million | 74.78 Million | 79.01 Million | 76.69 Million | 66.49 Million | 56.74 Million |
| Selling, General and Administrative Expenses | 10.57 Million | 15.78 Million | 10.87 Million | 11.08 Million | 9.42 Million | 7.56 Million |
| Research and Development Expenses | 54.6 Million | 60.33 Million | 62.28 Million | 59.48 Million | 50.43 Million | 44.27 Million |
| Other Expenses | -51.36 Million | -1.34 Million | 5.84 Million | 6.11 Million | 6.63 Million | 4.9 Million |
| Cost and Expenses | 68.42 Million | 74.78 Million | 79.01 Million | 76.69 Million | 66.49 Million | 56.74 Million |
| Operating Income | -53.62 Million | -70.84 Million | -79.01 Million | -61.26 Million | 44.53 Million | -49.55 Million |
| Interest Expense | 176 Thousand | 355 Thousand | 581 Thousand | 184 Thousand | 1.89 Million | 298 Thousand |
| Income Tax Expense | 10 Thousand | 13 Thousand | 3000.00 | 184 Thousand | 1.89 Million | -1.1 Million |
| Earnings before Tax | -54.22 Million | -70.74 Million | -72.99 Million | -61.92 Million | 45.44 Million | -50.95 Million |
| Net Income | -54.23 Million | -70.75 Million | -72.99 Million | -62.1 Million | 45.44 Million | -50.95 Million |
| Earnings Per Share Basic | -0.64 | -0.85 | -0.97 | -0.86 | 0.64 | -0.82 |
| Earnings Per Share Diluted | -0.64 | -0.85 | -0.97 | -0.86 | 0.64 | -0.82 |
| Weighted Average Shares Outstanding | 84.69 Million | 83.55 Million | 74.95 Million | 71.9 Million | 70.6 Million | 61.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 84.69 Million | 83.55 Million | 74.95 Million | 71.9 Million | 71.1 Million | 61.83 Million |
| Gross Margin | -2.69 | -14.33 | - | -2.86 | 0.55 | -5.15 |
| EBIT Margin | -3.50 | -17.99 | - | -3.84 | 0.42 | -6.74 |
| Profit Margin | -3.66 | -17.98 | - | -4.02 | 0.41 | -7.08 |
| EBITDA | -51.83 Million | -69.05 Million | -77.11 Million | -61.26 Million | 44.53 Million | -49.65 Million |
| Earnings Before Tax Margin | -3.62 | -18.00 | - | -3.97 | 0.40 | -6.89 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 687 Thousand | - | 14.8 Million | 14.8 Million | - | - |
| Cost of Revenue | 17.13 Million | 15.16 Million | 14.64 Million | 54.6 Million | 12.4 Million | 13.68 Million |
| Gross Profit | -16.45 Million | -15.16 Million | 157 Thousand | -39.8 Million | -12.4 Million | -13.68 Million |
| Operating Expenses | 21.64 Million | 20.06 Million | 18.34 Million | 68.42 Million | 15.46 Million | 17.04 Million |
| Selling, General and Administrative Expenses | 4.55 Million | 4.97 Million | -676 Thousand | - | 3.46 Million | 3.68 Million |
| Research and Development Expenses | 17.13 Million | 15.16 Million | 14.64 Million | - | 12.4 Million | 13.68 Million |
| Other Expenses | -17.17 Million | - | - | - | - | - |
| Cost and Expenses | 21.64 Million | 20.06 Million | 18.34 Million | 68.42 Million | 15.46 Million | 17.04 Million |
| Operating Income | -20.96 Million | -20.06 Million | -3.54 Million | -53.62 Million | -15.46 Million | -17.04 Million |
| Interest Expense | 34 Thousand | 36 Thousand | 26 Thousand | 176 Thousand | 26 Thousand | 27 Thousand |
| Income Tax Expense | 34 Thousand | 36 Thousand | 1000.00 | 10 Thousand | 3000.00 | 3000.00 |
| Earnings before Tax | -22.76 Million | -17.86 Million | -4.74 Million | -54.22 Million | -15.14 Million | -16.83 Million |
| Net Income | -22.76 Million | -17.86 Million | -4.74 Million | -54.23 Million | -15.14 Million | -16.83 Million |
| Earnings Per Share Basic | -0.23 | -0.18 | -0.05 | - | -0.18 | -0.20 |
| Earnings Per Share Diluted | -0.23 | -0.18 | -0.05 | - | -0.18 | -0.20 |
| Weighted Average Shares Outstanding | 99.54 Million | 99.38 Million | 86.74 Million | 84.69 Million | 84.71 Million | 84.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.54 Million | 99.38 Million | 86.74 Million | 84.69 Million | 84.71 Million | 84.61 Million |
| Gross Margin | -23.95 | - | 0.01 | -2.69 | - | - |
| EBIT Margin | -28.64 | - | -0.28 | - | - | - |
| Profit Margin | -33.13 | - | -0.32 | -3.66 | - | - |
| EBITDA | -19.67 Million | -18.88 Million | -4.16 Million | - | -14.63 Million | -16.24 Million |
| Earnings Before Tax Margin | -30.51 | - | -0.24 | -3.62 | - | - |
3434
0720
THMO
MRRTY
NWH-UN
3999